Cue Health will lay off 388 employees, about 26% of its workforce, as part of a larger cost-reduction plan.
The cuts mark another round of layoffs for the home diagnostics company, which laid off 170 manufacturing workers in the summer. In a filing with the Securities and Exchange Commission, Cue said the layoffs are expected to take place in March.
"For the past several months, the Cue Health...
Morgan Health, JPMorgan Chase's healthcare business unit, announced a $20 million strategic investment in home diagnostics startup LetsGetChecked.
The investment was made as part of a Series D-2 round led by Casdin Capital and Transformation Capital. LetsGetChecked closed a $150 million Series D round last year, building on raises in 2018, 2019 and 2020.
WHAT THEY DO
LetsGetChecked offers at-...
Diagnostics giant Labcorp is partnering with Getlabs to offer at-home sample collection for lab tests.
With the service, dubbed Getlabs for Labcorp, users can schedule an appointment online for an at-home blood draw. The phlebotomist can collect other samples like saliva, stool, urine and breath, and also measure vital signs. The collection will cost a convenience fee starting at $25.
Miami, Fla...
Cue Health, best known for its at-home COVID-19 molecular test, will launch its own virtual health platform, pushing the company outside of the diagnostics space.
The direct-to-consumer platform, available on Nov. 15, will include on-demand access to doctors, guided COVID-19 testing, prescriptions and physician-ordered lab tests. The virtual care offerings are part of a membership program, where...
Tokyo-based health and wellness startup Bisu has raised $3.2 million in a seed funding round led by South Korean biotechnology investor QUAD. The investing event was also joined by ASICS Ventures Corporation, 15th Rock Ventures, Pacifico Investments and SOSV.
WHAT IT'S FOR
Its seed funding will be used to formally bring into market its portable "home health lab" called Bisu Body Coach. The...
This morning, direct-to-consumer virtual health company Ro announced its plans to buy at-home diagnostic company Kit for an undisclosed sum. This marks the company’s second acquisition in two months.
Kit developed a system that allows patients to self-administer an at-home sample collection. Before taking the sample, patients are asked to download the corresponding app, which contains step-by-...
Yesterday afternoon, the U.S. FDA issued an Emergency Use Authorization (EUA) to a COVID-19 molecular diagnostic test that provides individuals with a result within 30 minutes, in the comfort of their home.
As opposed to currently available at-home testing products, which have patients self-collect a nasal swab sample and ship it for processing in a lab, the Lucira COVID-19 All-in-One Test Kit...
Last week saw a number of diagnostic testing startups, telehealth providers and others announce new services that would deliver at-home COVID-19 testing-kits to consumers. But the majority of these of offerings have since been rescinded or hang in doubt thanks to new warnings and regulatory clarifications issued this weekend by the FDA.
On Friday evening, the agency released an alert to consumers...
